Chinese consider trial protocols for traditional meds

Drug experts in China are creating clinical trial protocols for traditional Chinese medicines in an attempt to hasten market acceptance. Traditional development yields customized treatments based on individual demands rather than the principles of modern medicine, posing a difficult match-up between Western drug approval standards and Eastern medicine development. But use of the so-called circular model of drug development, which contrasts with the regulated hierarchical model of the East, may help balance the two methods for a truer assessment of traditional Chinese medicine. Article

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.